AeroLeads people directory · profile
Kent Payne Email & Phone Number
Managing Director
at
Wilmington PharmaTech Company LLC
1 work email found
@catalent.com
1 phone found area 919
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 86%
Who is Kent Payne? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Kent Payne is listed as Managing Director at Wilmington PharmaTech Company LLC, based in United States. AeroLeads shows a work email signal at catalent.com, phone signal with area code 919, and a matched LinkedIn profile for Kent Payne.
Kent Payne previously worked as Chief Executive Officer at Aliri and Senior Advisor, Pharma Services at Curewell Capital.
Company email context
Email format at Wilmington PharmaTech Company LLC
This section adds company-level context without repeating Kent Payne's masked contact details.
{first}.{last}@catalent.com
86% confidence
AeroLeads found 1 current-domain work email signal for Kent Payne. Compare company email patterns before reaching out.
Profile bio
About Kent Payne
Executive• Chief Executive Officer• P&L, multi-site, global responsibility >3,000 employees• Contract Research (CRO), discovery research target identification, lead identification, optimization• Contract Development and Manufacturing (CDMO) CRDMO• Large molecule biologics, gene editing through API manufacturing • Small molecule, process optimization, scale-up, • GMP Manufacturing (clinical and commercial)• M&A and post-merger integrationGlobal Leader• Brazil, China, EU, Japan and US• Fortune 500, Private Equity and start up environments• Agility across biotechnology and pharmaceutical market segments• Combine Strong Business Leadership with Scientific Expertise to drive financial value• Commercialization of proprietary platform technologies (gene expression, drug delivery)• Rx brand, generic and OTC products across sterile, inhalation, oral, topical and combined drug, device technology platforms• Sterile, inhalation, oral, topical and combined drug, device technology productsBoard Director Experienced Director on affiliate and outside boards providing executive, strategic, licensing and operational advisory leadership.
Listed skills include Fda, Pharmaceutical Industry, Biotechnology, Biopharmaceuticals, and 47 others.
Current workplace
Kent Payne's current company
Company context helps verify the profile and gives searchers a useful next step.
14 roles · 18 years
Kent Payne work experience
A career timeline built from the work history available for this profile.
Chief Executive Officer
Current
Jan 2024 - Present
Senior Advisor, Pharma Services
Current
Sep 2023 - Present
Board Member
Current
Aug 2019 - Present
Ceo At Bioduro-Sundia (An Advent International Company)
Dec 2019 - Jul 2023
Partner
Asklepios Capital Llc
Focused on advancing biotechnology and lifescience to improve the human condition, provides angel funding, management coaching, and director services to biotechnology start-ups.
Aug 2006 - Feb 2022
Ceo
Socorro Pharmaceuticals
Socorro is a Generic Pharmaceutical Company focused on finding P-IV ANDA opportunities on its own, or in partnerships with other generic drug companies, and providing the resources necessary to achieve market entry before the patents on a branded drug expire.
Feb 2017 - Apr 2019
Corporate Strategy Advisor
Life Science Institute, Inc. (A Subsidiary Of Mitsubishi Chemical Holdings)
Life Science Institute, Inc. was established on April 1, 2014 with a view to enhancing and expanding the Mitsubishi Chemical Holdings Corporation Group’s healthcare businesses. Our vision is to become a world leading provider of health care solutions.
Feb 2015 - Oct 2016
President And Board Director
Qualicaps® specializes in two-piece capsules, which have been the delivery system of choice for primary and contract manufacturers of pharmaceutical dosage forms for more than a century. Qualicaps® offers a variety of two-piece capsules in both gelatin and hypromellose (Quali-V®) options. Successful acquisition and integration of sole Brazilian manufacturer with more than 50% market share.
2014 - Oct 2016
Partner And Principal Consultant
Corefactor
Through our global topical expert network, CoreFactor is able to access complimentary resources to provide custom solutions for our clients. Services include:- Compliance- General Management- Licensing/M&A due diligence- Operational Excellence- Strategic planning- Product Development
Jan 2013 - Sep 2014
Non-Executive Chairman
Pds Biotechnology
A privately held biopharmaceutical company applying the platform Versamune™ nanotechnology to a new class of safe, simple, potent and targeted immunotherapies for the treatment of cancer and infectious diseases leading to potent curative and preventative immune responses. The first Versamune™-based product, Versamune™-HPV will enter human clinical trials in 2013.
2009 - 2014
~5 yrs
Vice President/General Manager
Catalent Biologics - Created and delivered successful strategy for biologics segment. Lead geographic growth opportunities in Japan, EU and BRIC countries with significantly increased market recognition. $26M move/expansion of Madison bioreactor facility. Partnerships announced with Toyobo Biologics, CEVEC, Euclid, Nascent. Strategic focus led to successful licensing of Redwood Biosciences ADC technology.Respiratory and Development Solutions - championed inhalation as new growth segment including first to file Albuterol partnership with Perrigo. Implemented sales visual control metrics and Value Pricing processes improving win rates by >20%. Implemented Lean System for Managing, improved laboratory and manufacturing on time delivery and right first time metrics resulting in over $3M savings annually
Jul 2007 - Jan 2013
Vice President & General Manager
Embedded new leadership and rationalized offerings to turn around two cash negative businesses, Strategically championed respiratory and development solutions as new growth segment including first to file Albuterol partnership with Perrigo. Implemented sales visual control metrics and Value Pricing processes improving win rates by >20%. Improved on time delivery and right first time metrics resulting in over $3M savings annually.
Aug 2005 - Jul 2007
Vp R&D
Led pharmaceutical services business. Markets served: Oral and Topical Technologies from pre-formulation through commercialization. Supported numerous customer IND/CTX and US and global commercial registration including development and commercialization of: Advil® PM Liquigels®, Advil® Cold and Sinus Liquigels®, Omacor® and Zemplar(R)®
Sep 2004 - Aug 2005
FAQ
Frequently asked questions about Kent Payne
Quick answers generated from the profile data available on this page.
What company does Kent Payne work for?
Kent Payne works for Wilmington PharmaTech Company LLC.
What is Kent Payne's role at Wilmington PharmaTech Company LLC?
Kent Payne is listed as Managing Director at Wilmington PharmaTech Company LLC.
What is Kent Payne's email address?
AeroLeads has found 1 work email signal at @catalent.com for Kent Payne at Wilmington PharmaTech Company LLC.
What is Kent Payne's phone number?
AeroLeads has found 1 phone signal(s) with area code 919 for Kent Payne at Wilmington PharmaTech Company LLC.
Where is Kent Payne based?
Kent Payne is based in United States while working with Wilmington PharmaTech Company LLC.
What companies has Kent Payne worked for?
Kent Payne has worked for Wilmington Pharmatech Company Llc, Aliri, Curewell Capital, Goodwin Biotechnology, Inc., and Bioduro-Sundia.
How can I contact Kent Payne?
You can use AeroLeads to view verified contact signals for Kent Payne at Wilmington PharmaTech Company LLC, including work email, phone, and LinkedIn data when available.
What skills is Kent Payne known for?
Kent Payne is listed with skills including Fda, Pharmaceutical Industry, Biotechnology, Biopharmaceuticals, Technology Transfer, R&D, Commercialization, and Gmp.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial